Androgen Receptor Expression Is a Significant Prognostic Factor in Estrogen Receptor Positive Breast Cancers Treated with Chemo-Endocrine Therapy

被引：0
|
作者：
Castellano, I.
Allia, E.
Accortanzo, V.
Vandone, A. M.
Chiusa, L.
Arisio, R.
Durando, A.
Donadio, M.
Bussolati, G.
Coates, A. S.
Viale, G.
Sapino, A.
机构：
[1] Univ Turin, Turin, Italy
[2] St Anna Hosp, Turin, Italy
[3] Molinette Mauriziano Hosp, Turin, Italy
[4] Univ Sydney, Sydney, NSW 2006, Australia
[5] European Inst Oncol, Milan, Italy
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
163
引用
收藏
页码：39A / 39A
页数：1
相关论文
共 50 条
  • [31] Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer
    Ma, Cynthia X.
    Bose, Ron
    Ellis, Matthew J.
    NOVEL BIOMARKERS IN THE CONTINUUM OF BREAST CANCER, 2016, 882 : 125 - 154
  • [32] Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer
    Tokunaga, Eriko
    Hisamatsu, Yuichi
    Taketani, Kenji
    Yamashita, Nami
    Akiyoshi, Sayuri
    Okada, Satoko
    Tanaka, Kimihiro
    Saeki, Hiroshi
    Oki, Eiji
    Aishima, Shinichi
    Oda, Yoshinao
    Morita, Masaru
    Maehara, Yoshihiko
    CANCER MEDICINE, 2013, 2 (06): : 763 - 773
  • [33] Androgen receptor immunoexpression in triple-negative breast cancers: is it a prognostic factor?
    Zaborowski, Matthew
    Pearson, Antonia
    Sioson, Loretta
    Gill, Anthony J.
    Ahadi, Mahsa S.
    PATHOLOGY, 2019, 51 (03) : 327 - 329
  • [34] The Implication of Androgen Receptor Expression in Breast Cancers
    Park, S.
    Koo, J. S.
    Kim, M. S.
    Park, H. S.
    Lee, J. S.
    Lee, J. S.
    Kim, S. I.
    Park, B-W
    CANCER RESEARCH, 2010, 70
  • [35] Androgen Receptor Positive Breast Cancers Are Associated with Better Prognosis Compared with Androgen Receptor Negative Cancers
    Richard, H. T.
    Bergeron, J. P.
    Almenara, J. A.
    Idowu, M. O.
    MODERN PATHOLOGY, 2012, 25 : 63A - 63A
  • [36] Androgen Receptor Positive Breast Cancers Are Associated with Better Prognosis Compared with Androgen Receptor Negative Cancers
    Richard, H. T.
    Bergeron, J. P.
    Almenara, J. A.
    Idowu, M. O.
    LABORATORY INVESTIGATION, 2012, 92 : 63A - 63A
  • [37] Bevacizumab combined with chemo-endocrine preoperative therapy in locally advanced operable breast cancers.
    Ferrari, B.
    Scarano, E.
    Pietri, E.
    Dellapasqua, S.
    Colleom, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S187 - S187
  • [38] UPDATE IN ENDOCRINE AND TARGETED THERAPY IN ESTROGEN-RECEPTOR POSITIVE, HER2 NEGATIVE BREAST CANCERS
    De La Fuente Joana, Izquierdo
    Ibanez Blanca, Gil
    Nuno, Conti
    Beatrice
    Parra Laura, Beltran
    Fernandez Guillermo, Lizana
    Sanchez Sofia, Aragon
    Maria Consuelo, Sanz Ferrandez
    ANTICANCER RESEARCH, 2023, 43 (07) : 3380 - 3380
  • [39] The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer
    Lim, Elgene
    Hickey, Theresa A.
    Selth, Luke A.
    Chia, Kee Ming
    Milioli, Heloisa H.
    Roden, Daniel
    Laven-Law, Geraldine
    Jindal, Shalini
    Hui, Mun
    Ebrahimie, Esmaeil
    Birrell, Stephen N.
    Stelloo, Suzan
    Caldon, C. Elizabeth
    Finlay-Schultz, Jessica
    Abdel-Fatah, Tarek M.
    Ellis, Ian O.
    Zwart, Willbert
    Palmieri, Carlo
    Sartorius, Carol A.
    Swarbrick, Alex
    Carroll, Jason S.
    Tilley, Wayne D.
    CANCER RESEARCH, 2020, 80 (04)
  • [40] The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
    Theresa E. Hickey
    Luke A. Selth
    Kee Ming Chia
    Geraldine Laven-Law
    Heloisa H. Milioli
    Daniel Roden
    Shalini Jindal
    Mun Hui
    Jessica Finlay-Schultz
    Esmaeil Ebrahimie
    Stephen N. Birrell
    Suzan Stelloo
    Richard Iggo
    Sarah Alexandrou
    C. Elizabeth Caldon
    Tarek M. Abdel-Fatah
    Ian O. Ellis
    Wilbert Zwart
    Carlo Palmieri
    Carol A. Sartorius
    Alex Swarbrick
    Elgene Lim
    Jason S. Carroll
    Wayne D. Tilley
    Nature Medicine, 2021, 27 : 310 - 320
12345